Pubblicazioni dei membri dell’Associazione

Lavori pubblicati su riviste internazionali dotate di Impact Factor.

  1. Pedrazzoli S. Pancreatoduodenectomy (PD) and postoperative pancreatic fistula (POPF): A systematic review and analysis of the POPF-related mortality rate in 60,739 patients retrieved from the English literature published between 1990 and 2015. Medicine (Baltimore). 2017 May;96(19):e6858.
  2. Mohelnikova-Duchonova B, Strouhal O, Hughes DJ, Holcatova I, Oliverius M, Kala Z, Campa D, Rizzato C, Canzian F, Pezzilli R, Talar-Wojnarowska R, Malecka-Panas E, Sperti C, Federico Zambon C, Pedrazzoli S, Fogar P, Milanetto AC, Capurso G, Delle Fave G, Valente R, Gazouli M, Malleo G, Teresa Lawlor R, Strobel O, Hackert T, Giese N, Vodicka P, Vodickova L, Landi S, Tavano F, Gioffreda D, Piepoli A, Pazienza V, Mambrini A, Pedata M, Cantore M, Bambi F, Ermini S, Funel N, Lemstrova R, Soucek P. SLC22A3 polymorphisms do not modify pancreatic cancer risk, but may influence overall patient survival. Sci Rep. 7:43812, 2017.
  3. Sperti C, Moletta L, Pozza G. Pancreatic resection in very elderly patients: A critical analysis of existing evidence. World J Gastrointest Oncol. 9:30-36, 2017.
  4. Beltrame V, Pozza G, Dalla Bona E, Fantin A, Valmasoni M, Sperti C. Solid-Pseudopapillary tumor of the pancreas: a single center experience. Gastroenterol Res Pract. 2016; 2016:4289736 5.    Campa D, Capurso G, Pastore M, Talar-Wojnarowska R, Milanetto AC, Landoni L, Maiello E, Lawlor RT, Malecka-Panas E, Funel N, Gazouli M, De Bonis A, Klüter H, Rinzivillo M, Delle Fave G, Hackert T, Landi S, Bugert P, Bambi F, Archibugi L, Scarpa A, Katzke V, Dervenis C, Liço V, Furlanello S, Strobel O, Tavano F, Basso D, Kaaks R, Pasquali C, Gentiluomo M, Rizzato C, Canzian F. Common germline variants within the CDKN2A/2B region affect risk of pancreatic neuroendocrine tumors. Sci Rep. 6:39565, 2016.
  5. Campa D, Pastore M, Gentiluomo M, Talar-Wojnarowska R, Kupcinskas J, Malecka-Panas E, Neoptolemos JP, Niesen W, Vodicka P, Delle Fave G, Bueno-de-Mesquita HB, Gazouli M, Pacetti P, Di Leo M, Ito H, Klüter H, Soucek P, Corbo V, Yamao K, Hosono S, Kaaks R, Vashist Y, Gioffreda D, Strobel O, Shimizu Y, Dijk F, Andriulli A, Ivanauskas A, Bugert P, Tavano F, Vodickova L, Zambon CF, Lovecek M, Landi S, Key TJ, Boggi U, Pezzilli R, Jamroziak K, Mohelnikova-Duchonova B, Mambrini A, Bambi F, Busch O, Pazienza V, Valente R, Theodoropoulos GE, Hackert T, Capurso G, Cavestro GM, Pasquali C, Basso D, Sperti C, Matsuo K, Büchler M, Khaw KT, Izbicki J, Costello E, Katzke V, Michalski C, Stepien A, Rizzato C, Canzian F. Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk. Oncotarget. 7:57011-57020, 2016.
  6. Jais B, Rebours V, Malleo G, Salvia R, Fontana M, Maggino L, Bassi C, Manfredi R, Moran R, Lennon AM, Zaheer A, Wolfgang C, Hruban R, Marchegiani G, Fernández Del Castillo C, Brugge W, Ha Y, Kim MH, Oh D, Hirai I, Kimura W, Jang JY, Kim SW, Jung W, Kang H, Song SY, Kang CM, Lee WJ, Crippa S, Falconi M, Gomatos I, Neoptolemos J, Milanetto AC, Sperti C, Ricci C, Casadei R, Bissolati M, Balzano G, Frigerio I, Girelli R, Delhaye M, Bernier B, Wang H, Jang KT, Song DH, Huggett MT, Oppong KW, Pererva L, Kopchak KV, Del Chiaro M, Segersvard R, Lee LS, Conwell D, Osvaldt A, Campos V, Aguero Garcete G, Napoleon B, Matsumoto I, Shinzeki M, Bolado F, Fernandez JM, Keane MG, Pereira SP, Acuna IA, Vaquero EC, Angiolini MR, Zerbi A, Tang J, Leong RW, Faccinetto A, Morana G, Petrone MC, Arcidiacono PG, Moon JH, Choi HJ, Gill RS, Pavey D, Ouaïssi M, Sastre B, Spandre M, De Angelis CG, Rios-Vives MA, Concepcion-Martin M, Ikeura T, Okazaki K, Frulloni L, Messina O, Lévy P. Serous cystic neoplasm of the pancreas: a multinational study of 2622 patients under the auspices of the International Association of Pancreatology and European Pancreatic Club (European Study Group on Cystic Tumors of the Pancreas). Gut. 65:305-12, 2016  
  7. Moz S, Basso D, Padoan A, Bozzato D, Fogar P, Zambon CF, Pelloso M, Sperti C, Vigili de Kreutzenberg S, Pasquali C, Pedrazzoli S, Avogaro A, Plebani M. Blood expression of matrix metalloproteinases 8 and 9 and of their inducers S100A8 and S100A9 supports diagnosis and prognosis of PDAC-associated diabetes mellitus. Clin Chim Acta. 456:24-30, 2016.
  8. Moz S, Basso D, Bozzato D, Galozzi P, Navaglia F, Negm OH, Arrigoni G, Zambon CF, Padoan A, Tighe P, Todd I, Franchin C, Pedrazzoli S, Punzi L, Plebani M. SMAD4 loss enables EGF, TGFβ1 and S100A8/A9 induced activation of critical pathways to invasion in human pancreatic adenocarcinoma cells. Oncotarget. 7:69927-69944, 2016.
  9. Partelli S, Tamburrino D, Lopez C, Albers M, Milanetto AC, Pasquali C, Manzoni M, Toumpanakis C, Fusai G, Bartsch D, Falconi M. Active surveillance versus surgery of nonfunctioning pancreatic neuroendocrine neoplasms ≤2 cm in MEN1 patients. Neuroendocrinology. 103:779-86, 2016.   11. Rizzato C, Campa D, Talar-Wojnarowska R, Halloran C, Kupcinskas J, Butturini G, Mohelníková-Duchoňová B, Sperti C, Tjaden C, Ghaneh P, Hackert T, Funel N, Giese N, Tavano F, Pezzilli R, Pedata M, Pasquali C, Gazouli M, Mambrini A, Souček P, di Sebastiano P, Capurso G, Cantore M, Oliverius M, Offringa R, Małecka-Panas E, Strobel O, Scarpa A, Canzian F. Association of genetic polymorphisms with survival of pancreatic ductal adenocarcinoma patients. Carcinogenesis. 37:957-64, 2016.
  10. Sperti C, Pozza G, Brazzale AR, Buratin A, Moletta L, Beltrame V, Valmasoni M. Metastatic tumors to the pancreas: a systematic review and meta-analysis. Minerva Chir. 71:337-44, 2016.
  11. Zhang M, Wang Z, Obazee O, Jia J, Childs EJ, Hoskins J, Figlioli G, Mocci E, Collins I, Chung CC, Hautman C, Arslan AA, Beane-Freeman L, Bracci PM, Buring J, Duell EJ, Gallinger S, Giles GG, Goodman GE, Goodman PJ, Kamineni A, Kolonel LN, Kulke MH, Malats N, Olson SH, Sesso HD, Visvanathan K, White E, Zheng W, Abnet CC, Albanes D, Andreotti G, Brais L, Bueno-de-Mesquita HB, Basso D, Berndt SI, Boutron-Ruault MC, Bijlsma MF, Brenner H, Burdette L, Campa D, Caporaso NE, Capurso G, Cavestro GM, Cotterchio M, Costello E, Elena J, Boggi U, Gaziano JM, Gazouli M, Giovannucci EL, Goggins M, Gross M, Haiman CA, Hassan M, Helzlsouer KJ, Hu N, Hunter DJ, Iskierka-Jazdzewska E, Jenab M, Kaaks R, Key TJ, Khaw KT, Klein EA, Kogevinas M, Krogh V, Kupcinskas J, Kurtz RC, Landi MT, Landi S, Le Marchand L, Mambrini A, Mannisto S, Milne RL, Neale RE, Oberg AL, Panico S, Patel AV, Peeters PH, Peters U, Pezzilli R, Porta M, Purdue M, Quiros JR, Riboli E, Rothman N, Scarpa A, Scelo G, Shu XO, Silverman DT, Soucek P, Strobel O, Sund M, Małecka-Panas E, Taylor PR, Tavano F, Travis RC, Thornquist M, Tjønneland A, Tobias GS, Trichopoulos D, Vashist Y, Vodicka P, Wactawski-Wende J, Wentzensen N, Yu H, Yu K, Zeleniuch-Jacquotte A, Kooperberg C, Risch HA, Jacobs EJ, Li D, Fuchs C, Hoover R, Hartge P, Chanock SJ, Petersen GM, Stolzenberg-Solomon RS, Wolpin BM, Kraft P, Klein AP, Canzian F, Amundadottir LT. Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21. Oncotarget. 7:66328-66343, 2016.
  12. Nadal E, Burra P, Mescoli C, Albertoni L, Sperti C, Sturniolo GC, Fantin A. Pancreatic melanoma metastasis diagnosed by endoscopic ultrasound-guided SharkCore biopsy. Endoscopy. 48 Suppl 1:E208-9, 2016.
  13. Beltrame V, Gruppo M, Pastorelli D, Pedrazzoli S, Merigliano S, Sperti C. Outcome of pancreaticoduodenectomy in octogenarians: Single institution’s experience and review of the literature. J Visc Surg.152:279-84, 2015.
  14. Beltrame V, Gruppo M, Pedrazzoli S, Merigliano S, Pastorelli D, Sperti C.Mesenteric-Portal Vein Resection during pancreatectomy for Pancreatic Cancer. Gastroenterol Res and Practice. 2015;2015:659730.
  15. Campa D, Rizzato C, Stolzenberg-Solomon R, Pacetti P, Vodicka P, Cleary SP, Capurso G, Bueno-de-Mesquita HB, Werner J, Gazouli M, Butterbach K, Ivanauskas A, Giese N, Petersen GM, Fogar P, Wang Z, Bassi C, Ryska M, Theodoropoulos GE, Kooperberg C, Li D, Greenhalf W, Pasquali C, Hackert T, Fuchs CS, Mohelnikova-Duchonova B, Sperti C, Funel N, Dieffenbach AK, Wareham NJ, Buring J, Holcátová I, Costello E, Zambon CF, Kupcinskas J, Risch HA, Kraft P, Bracci PM, Pezzilli R, Olson SH, Sesso HD, Hartge P, Strobel O, Małecka-Panas E, Visvanathan K, Arslan AA, Pedrazzoli S, Souček P, Gioffreda D, Key TJ, Talar-Wojnarowska R, Scarpa A, Mambrini A, Jacobs EJ, Jamroziak K, Klein A, Tavano F, Bambi F, Landi S, Austin MA, Vodickova L, Brenner H, Chanock SJ, Delle Fave G, Piepoli A, Cantore M, Zheng W, Wolpin BM, Amundadottir LT, Canzian F. The TERT gene harbors multiple variants associated with pancreatic cancer susceptibility. Int J Cancer. 137: 2175-2183, 2015.
  16. Canton SA, Merigliano S, Pasquali C. Prosthetic mesh “slim-cigarette like” for laparoscopic repair of ventral hernias: a new technique without transabdominal fixation sutures. Updates Surg. 68:199-203, 2016.
  17. Milanetto AC, Liço V, Blandamura S, Pasquali C. Primary leiomyosarcoma of the pancreas: report of a case treated by local excision and review of the literature. Surg Case Rep. 1:98, 2015.
  18. Childs EJ, Mocci E, Campa D, Bracci PM, Gallinger S, Goggins M, Li D, Neale RE, Olson SH, Scelo G, Amundadottir LT, Bamlet WR, Bijlsma MF, Blackford A, Borges M, Brennan P, Brenner H, Bueno-de-Mesquita HB, Canzian F, Capurso G, Cavestro GM, Chaffee KG, Chanock SJ, Cleary SP, Cotterchio M, Foretova L, Fuchs C, Funel N, Gazouli M, Hassan M, Herman JM, Holcatova I, Holly EA, Hoover RN, Hung RJ, Janout V, Key TJ, Kupcinskas J, Kurtz RC, Landi S, Lu L, Malecka-Panas E, Mambrini A, Mohelnikova-Duchonova B, Neoptolemos JP, Oberg AL, Orlow I, Pasquali C, Pezzilli R, Rizzato C, Saldia A, Scarpa A, Stolzenberg-Solomon RZ, Strobel O, Tavano F, Vashist YK, Vodicka P, Wolpin BM, Yu H, Petersen GM, Risch HA, Klein AP. Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer. Nat Genet. 47:911-16, 2015.
  19. Battocchio M, Zatelli MC, Chiarelli S, Trento M, Ambrosio MR, Pasquali C, De Carlo E, Dassie F, Mioni R, Rebellato A, Fallo F, Degli Uberti E, Martini C, Vettor R, Maffei P. Ovarian tumors secreting insulin. Endocrine. 49:611-19, 2015.
  20. Derikx MH, Kovacs P, Scholz M, Masson E, Chen JM, Ruffert C, Lichtner P, Te Morsche RH, Cavestro GM; PanEuropean Working group on Alcoholic Chronic Pancreatitis members and collaborators, Férec C, Drenth JP, Witt H, Rosendahl J, Algül H, Berg T, Bödeker H, Blüher M, Bruno MJ, Buch S, Bugert P, Cichoz-Lach H, Dabrowski A, Farré A, Frank J, Gasiorowska A, Geisz A, Goni E, Grothaus J, Grützmann R, Haas S, Hampe J, Hellerbrand C, Hegyi P, Huster D, Ioana M, Iordache S, Jurkowska G, Keim V, Landt O, Di Leo M, Lerch MM, Lévy P, Löhr MJ, Macek M, Malats N, Malecka-Panas E, Mariani A, Martorana D, Mayerle J, Mora J, Mössner J, Müller S, Ockenga J, Paderova J, PEDRAZZOLI S, Pereira SP, Pfützer R, Real FX, Rebours V, Ridinger M, Rietschel M, Rohde K, Sack S, Saftoiu A, Schneider A, Schulz HU, Soyka M, Simon P, Skipworth J, Stickel F, Stumvoll M, Testoni PA, Tönjes A, Treiber M, Weiss FU, Werner J, Wodarz N. Polymorphism at PRSS1-PRSS2 and CLDN2-MORC4 loci associate with alcoholic and non-alcoholic chronic pancreatitis in a European replication study. Gut; 64:1426-33, 2015.
  21. Padoan A, Basso D, La Malfa M, Zambon CF, Aiyetan P, Zhang H, Di Chiara A, Pavanello G, Bellocco R, Chan DW, Plebani M. Reproducibility in urine peptidome profiling using MALDI-TOF. Proteomics. 15:1476-85, 2015.
  22. Pedrazzoli S. Extent of lymphadenectomy to associate with pancreaticoduodenectomy in patients with pancreatic cancer for better tumor staging. Cancer Treat Rev. 41:577-87, 2015.
  23. Sperti C, Moletta L, Merigliano S. Multimodality treatment of recurrent pancreatic cancer: Mith or reality? World J Gastrointest Oncol. 7:375-82, 2015.   26. Sperti C, Merigliano S, Moletta L. Metastatic pancreatic tumors: what is the optimal treatment? Minerva Chir. 70:131-9, 2015.   27. Valli V, Blandamura S, Pastorelli D, Merigliano S, Sperti C. Nesidioblastosis coexisting with non-functioning islet cell tumour in an adult. Endokrynol Pol. 66:356-60, 2015.
  24. Basso D, Bozzato D, Padoan A, Moz S, Zambon CF, Fogar P, Greco E, Scorzeto M, Simonato F, Navaglia F, Fassan M, Pelloso M, Dupont S, Pedrazzoli S, Fassina A, Plebani M. Inflammation and pancreatic cancer: molecular and functional interactions between S100A8, S100A9, NT-S100A8 and TGFbeta1. Cell Commun Signal.12:1-20, 2014.
  25. Beltrame V, Gruppo M, Pastorelli D, Pizzi S, Merigliano S, Sperti C. Extra-gastrointestinal stromal tumor of the pancreas: case report and review of the literature. World J Surg Oncol. 23;12:105, 2014.  
  26. Italian Association of Hospital Gastroenterologists and Endoscopists.; Italian Association for the Study of the Pancreas., Buscarini E, Pezzilli R, Cannizzaro R, De Angelis C, Gion M, Morana G, Zamboni G, Arcidiacono P, Balzano G, Barresi L, Basso D, Bocus P, Calculli L, Capurso G, Canzonieri V, Casadei R, Crippa S, D’Onofrio M, Frulloni L, Fusaroli P, Manfredi G, Pacchioni D, Pasquali C, Rocca R, Ventrucci M, Venturini S, Villanacci V, Zerbi A, Falconi M; Cystic Pancreatic Neoplasm Study Group. Italian consensus guidelines for the diagnostic work-up and follow-up of cystic pancreatic neoplasms. Dig Liver Dis. 46:479-93, 2014
  27. Moletta L, Milanetto AC, Vincenzi V, Alaggio R, Pedrazzoli S, Pasquali C. Pancreatic secondary lesions from Renal Cell Carcinoma. World J Surg. 38: 3002-3006, 2014.
  28. Porcu S, Lapolla A, Biasutto L, Zoratti M, Piarulli F, Eliana G, Basso D, Roverso M, Seraglia R. A preliminary fastview of mitochondrial protein profile from healthy and type 2 diabetic subjects. Eur J Mass Spectrom (Chichester). 20:307-15, 2014.
  29. Sperti C, Moletta L, Patanè G. Metastatic tumors to the pancreas: The role of surgery.  World J Gastrointest Oncol. 6:381-92, 2014.   34. Vincenzi M, Pasquotti G, Polverosi R, Pasquali C, Pomerri F. Imaging of pancreatic metastases from renal cell carcinoma. Cancer Imaging. 14: 5, 2014.
  30. Wolpin BM, Rizzato C, Kraft P, Kooperberg C, Petersen GM, Wang Z, Arslan AA, Beane-Freeman L, Bracci PM, Buring J, Canzian F, Duell EJ, Gallinger S, Giles GG, Goodman GE, Goodman PJ, Jacobs EJ, Kamineni A, Klein AP, Kolonel LN, Kulke MH, Li D, Malats N, Olson SH, Risch HA, Sesso HD, Visvanathan K, White E, Zheng W, Abnet CC, Albanes D, Andreotti G, Austin MA, Barfield R, Basso D, Berndt SI, Boutron-Ruault MC, Brotzman M, Büchler MW, Bueno-de-Mesquita HB, Bugert P, Burdette L, Campa D, Caporaso NE, Capurso G, Chung C, Cotterchio M, Costello E, Elena J, Funel N, Gaziano JM, Giese NA, Giovannucci EL, Goggins M, Gorman MJ, Gross M, Haiman CA, Hassan M, Helzlsouer KJ, Henderson BE, Holly EA, Hu N, Hunter DJ, Innocenti F, Jenab M, Kaaks R, Key TJ, Khaw KT, Klein EA, Kogevinas M, Krogh V, Kupcinskas J, Kurtz RC, LaCroix A, Landi MT, Landi S, Le Marchand L, Mambrini A, Mannisto S, Milne RL, Nakamura Y, Oberg AL, Owzar K, Patel AV, Peeters PH, Peters U, Pezzilli R, Piepoli A, Porta M, Real FX, Riboli E, Rothman N, Scarpa A, Shu XO, Silverman DT, Soucek P, Sund M, Talar-Wojnarowska R, Taylor PR, Theodoropoulos GE, Thornquist M, Tjønneland A, Tobias GS, Trichopoulos D, Vodicka P, Wactawski-Wende J, Wentzensen N, Wu C, Yu H, Yu K, Zeleniuch-Jacquotte A, Hoover R, Hartge P, Fuchs C, Chanock SJ, Stolzenberg-Solomon RS, Amundadottir LT. Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer. Nat Genet. 46:994-1000, 2014.
  31. Basso D, Fogar P, Plebani M. The S100A8/A9 complex reduces CTLA4 expression by immature myeloid cells: Implications for pancreatic cancer-driven immunosuppression. Oncoimmunology. 2:e24441, 2013.
  32. Campa D, Rizzato C, Capurso G, Giese N, Funel N, Greenhalf W, Soucek P, Gazouli M, Pezzilli R, Pasquali C, Talar-Wojnarowska R, Cantore M, Andriulli A, Scarpa A, Jamroziak K, Fave GD, Costello E, Khaw KT, Heller A, Key TJ, Theodoropoulos G, Malecka-Panas E, Mambrini A, Bambi F, Landi S, Pedrazzoli S, Bassi C, Pacetti P, Piepoli A, Tavano F, di Sebastiano P, Vodickova L, Basso D, Plebani M, Fogar P, Büchler MW, Bugert P, Vodicka P, Boggi U, Neoptolemos JP, Werner J, Canzian F. Genetic susceptibility to pancreatic cancer and its functional characterisation: The PANcreatic Disease ReseArch (PANDoRA) consortium. Dig Liver Dis. 45:95-9, 2013.
  33. Galli C, Basso D, Plebani M. CA 19-9: handle with care. Clin Chem Lab Med. 51:1369-83, 2013.
  34. Milanetto AC, Iaria L, Alaggio R, Pedrazzoli S, Pasquali C. Squamoid cyst of pancreatic ducts: a challenging differential diagnosis among benign pancreatic cysts. JOP. 14: 657-60, 2013.  
  35. Sperti C, Beltrame V, Bissoli S, Pedrazzoli S. Accuracy of CA 19-9 and Radiologic Imaging in detecting recurrence after resection for Pancreatic Cancer. 14: 657-60, 680-681, 2013.
  36. Zerbi A, Capitanio V, Boninsegna L, Delle Fave G, Pasquali C, Rindi G, Campana D, Falconi M, Di Carlo V, Pederzoli P, Delle Fave G, Pedrazzoli S, Tomassetti P, Garcea D, Uomo G, Colangelo E, Mosca F, Fronda GR, Bresadola F, Cantore M, Leone BE, Farinati F, Toma S, Luppi G, Bene A, Bajetta E, Ruffini L, Gebbia V, Liguori L, De Toma G, Dogliotti L, Massidda B). Treatment of malignant pancreatic neuroendocrine neoplasms: middle-term (2-year) outcomes of a prospective observational multicentre study. HPB (Oxford). 15:935-43, 2013.
  37. Seiler CM, Izbicki J, Varga-Szabó L, Czakó L, Fiók J, Sperti C, Lerch MM, Pezzilli R, Vasileva G, Pap A, Varga M, Friess H. Randomised clinical trial: a 1-week, double-blind, placebo-controlled study of pancreatin 25 000 Ph. Eur. minimicrospheres (Creon 25000 MMS) for pancreatic exocrine insufficiency after pancreatic surgery, with a 1-year open-label extension. Aliment Pharmacol Ther. 2013 Apr;37(7):691-702
  38. Basso D, Fogar P, Falconi M, Fadi E, Sperti C, Frasson C, Greco E, Tamburrino D, Teolato S, Moz S, Bozzato D, Pelloso M, Padoan A, De Franchis G, Gnatta E, Facco M, Zambon CF, Navaglia F, Pasquali C, Basso G, Semenzato G, Pedrazzoli S, Pederzoli P, Plebani M. Pancreatic tumors and immature immunosuppressive myeloid cells in blood and spleen: role of inhibitory co-stimulatory molecules PDL1 and CTLA4. An in vivo and in vitro study. PLoS One. 2013;8:e54824.
  39. Padoan A, Seraglia R, Basso D, Fogar P, Sperti C, Moz S, Greco E, Marchet A, de Manzoni G, Zambon CF, Navaglia F, Cristadoro L, Di Chiara A, Nitti D, Pedrazzoli S, Pavanello G, Plebani M.Usefulness of MALDI-TOF/MS Identification of Low-MW Fragments in Sera for the Differential Diagnosis of Pancreatic Cancer. 2013 May;42(4):622-32.
  40. Neoptolemos JP, Moore MJ, Cox TF, Valle JW, Palmer DH, McDonald AC, Carter R, Tebbutt NC, Dervenis C, Smith D, Glimelius B, Charnley RM, Lacaine F, Scarfe AG, Middleton MR, Anthoney A, Ghaneh P, Halloran CM, Lerch MM, Oláh A, Rawcliffe CL, Verbeke CS, Campbell F, Büchler MW; European Study Group for Pancreatic Cancer. Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial. JAMA 308:147-56, 2012.
  41. Montorsi M, Zerbi A, Bassi C, Capussotti L, Coppola R, Sacchi M; Italian Tachosil Study Group (Sperti C.). Efficacy of an absorbable fibrin sealant patch (TachoSil) after distal pancreatectomy: a multicenter, randomized, controlled trial. Ann Surg. 2012 Nov;256(5):853-9; discussion 859-60.
  42. Sperti C, Beltrame V, Bellamio B, Pasquali C. Spleen-preserving distal pancreatectomy with splenic vessels excision. Surgery 2012; 152: 140-141.
  43. Sperti C, Beltrame V, Tona F, Moro M, Pedrazzoli S, Pasquali C. Organ- preserving pancreatectomy for benign or border-line neoplasms of the pancreas. Eur J Clin Med Oncol 2012; 4(2): 55-66.
  44. Moletta L, Sperti C, Beltrame V, Gruppo M, Blandamura S, Pasquali C, Pedrazzoli S. Leiomyosarcoma of the pancreas with liver metastases as a paradigm of multimodality treatment. Case report and review of the literature. J Gastrointest Cancer 2012; Epub ahead of print.
  45. Beltrame V, Tona F, Andres AL, Sperti C. Epstein-Barr virus associated acute acalcolous cholecystitis in an adult. Am J Case Rep 2012; 13: 153-156.
  46. Dalla Bona E, Beltrame V, Blandamura S, Liessi F, Sperti C. Huge cystic lymphangioma of the pancreas mimicking pancreatic cystic neoplasm. Case Report Med 2012; Article ID 951358, 4 pages: doi:10.1155/2012/951358.
  47. Dalla Bona, Beltrame V, Liessi F, Sperti C. Fatal pneumococcal sepsis eleven years after distal pancretectomy with splenectomy for pancreatic cancer. JOP 13(6): 693-695, 2012.
  48. Pedrazzoli S, Sperti C, Pasquali C, Bissoli S, Chierichetti F. Comparison of International Consensus Guidelines versus 18-FDG PET in detecting maliganncy of intraductal papillary mucinous neoplasms of the pancreas. Ann Surg 2011; 254: 971-976.
  49. Pedrazzoli S, Canton A, Sperti C. Duodenum-preserving pancreatic head resection for benign and premalignant lesions. J Hepatobiliary Pancreat Sci 2011; 18: 94-102.
  50. Basso D, Greco E, Padoan A, Fogar P, et al. Altered intracellular calcium fluxes in pancreatic cancer induced diabetes mellitus: relevance of the S100A8 N-terminal peptide (NT-S100A8). J Cell Physiol 2011; 226: 456-68.
  51. Fogar P, Basso D, Fadi E, Greco E, Pantano G, Padoan A, Bozzato D, Facco M, Sanzari MC, Teolato S, Zambon CF, Navaglia F, Semenzato G, PEDRAZZOLI S, Plebani M. Pancreatic cancer alters human CD4+ T lymphocyte function: A piece in the immune evasion puzzle. Pancreas 40:1131-37, 2011.
  52. Moro M, Moletta L, Blandamura S, Sperti C. Acinar cell carcinoma of the pancreas associated with subcutaneous panniculitis. JOP. J Pancreas 2011; 12(3): 292-6.
  53. Sperti C, Berltrame V, Milanetto AC, Moro M, Pedrazzoli S. Parenchyma-sparing pancreatectomies for benign or border-line tumors of the pancreas. World J Gatrointest Oncol 2010; 2: 272-81.
  54. Greco E, Basso D, Fadi E, et al. Analogs of vitamin E epitomized by alpha-tocopheryl succinate for pancreatic cancer treatment: in vitro results induce caution for in vivo applications. Pancreas 2010; 39: 662-8.
  55. Fogar P, Navaglia F, Basso D, Zambon CF, et al. Heat-induced transcription of diphteria toxin A or its variants, CRM176 and CRM197: implications for pancreatic cancer gene therapy. Cancer Gene Ther 2010; 17: 58-68.
  56. Berselli M, Sperti C, Ballotta E, Beltrame V, Pedrazzoli S. Pancreaticoduodenectomy with unusual artery reconstruction in a patient with celiac axis occlusion: report of a case. Updates Surg 2010; 62: 117-20.
  57. Pedrazzoli S, Canton SA, Sperti C. Duodenum-preserving versus pylorus-preserving pancreatic head resection for benign and premalignant lesions. J Hepatobiliary Pancreat Sci. 17:203, 2010
  58. Sperti C, Berselli M, Pedrazzoli S. Distal pancreatectomy for body-tail pancreatic cancer: is there a role for celiac axis resection? Pancreatology 2010; 10: 491-8.
  59. Zerbi A, Capitanio V, Boninsegna l, Pasquali C, Rindi G, Delle Fave G, Del Chiaro M, Casadei R, Falconi M; AISP Network study Group. Surgical treatment of endocrine pancreatic tumors in Italy: results of a prospective multicentric study of 262 cases. Langenbecks Arch Surg 2011; 396: 313-21.
  60. Pedrazzoli S, Canton AS, Sperti C. The need of a severity scoring system for postoperative pancreatic fistula. J Gastrointest Surg 2010; 14: 1470-1
  61. Sperti C, Polizzi L, Beltrame V, Moro M, Pedrazzoli S. Pancreatic resection for metastatic melanoma: case report and review of the literature. J Gastrointest Cancer 42:302-6. 2010.
  62. Pedrazzoli S, Canton AS, Sperti C, Pasquali C. Parenchyma-sparing resection for pancreatic neoplasms. J Hepatobiliary Pancreat Sci 2010; 17: 203.
  63. Sperti C, Polizzi L, Moro M, Beltrame V, Pedrazzoli S. Middle-preserving pancreatectomy: an interesting procedure for pancreas-sparing resection. J Pancreas 2010; 11: 258-61.
  64. Sperti C, Pasquali C, Bissoli S, Chierichetti F, Liesii G, Pedrazzoli S. Tumor relapse after pancreatic cancer resection is detected earlier by 18-FDG PET than by CT. J Gastrointest Surg 2010; 14: 131-40.
  65. Zerbi A, Falconi M, Rindi G, Delle Fave G, Tomassetti P, Pasquali C, Capitanio V, Boninsegna L, Di Carlo V; AISP Network Study Group. Clinicopathological features of pancreatic endocrine tumors: a prospective multicentric study in Italy of 297 sporadic cases. Am J Gastroenterol 2010; 105: 1421-9.
  66. Frulloni L, Falconi M, Gabbrielli A, et al. (Pasquali C). Italian Consensus guidelines for chronic pancreatitis. Dig Liver Dis 2010; 42 (Suppl. 6: S381-406.
  67. Navaglia F, Fogar P, Basso D, Greco E, et al. Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry. Clin Chem Lab Med 2009; 47: 713-23.
  68. Cavallari I, Silic-Benussi M, Rende F, Martines A, Fogar P, et al. Decreased expression and promoter methylation of the menin tumor suppressor in pancreatic ductal adenocarcinoma. Genes Chromosomes Cancer 2009; 48: 383-96.
  69. Biasco G, Velo D, Angriman I, et al (Pasquali C); Section of Oncology of the Italian Society of Gastroenterology; Interdisciplinary GIST-group-G.I. GIST. Gastrointestinal stromal tumors: report of an audit and review of the literature. Eur J Cancer Prev 2009; 18: 106-16.
  70. Sperti C, Pasquali C, Berselli M, Frison L, Vicario G, Pedrazzoli S. Metastasi sto the pancreas from colorectal cancer: is there a place for pancreatic resection? Dis Colon rectum 2009; 52: 1154-9.
  71. Fassan M, Pizzi S, Pasquali C, Parenti AR. Pancreatic endocrine tumor in multipe endocrine neoplasia type 1 syndrome with intraductal growth into the main pancreatic duct. Pancreas 2009; 38: 341-42.
  72. Pedrazzoli S, Liessi G, Pasquali C, Ragazzi R, Berselli M, Sperti C. Postoperative pancreatic fistola: preventing severe complications and reducing reoperation and mortality rate. Ann Surg 2009; 249: 97-104.
  73. Pizzi S, Porzionato A, Pasquali C, Guidolin D, Sperti C, Fogar P, Macchi V, De Caro R, Pedarzzoli S, Parenti A. Glucose transporter-1 expression and prognostic significante in pancreatic carcinogenesis. Histol Histopathol 2009; 24:175-85.
  74. Pizzi S, Azzoni C, Tamburini E, Bottarelli L, Campanini N, D’Adda T, Fellegara G, Luong TV, Pasquali C, Rossi G, Delle Fave G, Camisa R, Bordi C, Rindi G. Adenomatous polyposis coli alteration in digestive endocrine tumors; correlation with nuclear trans location of beta-catenin and chromosomal instability. Endocr Relat Cancer 2008; 15: 1013-24.
  75. Fassan M, Pizzi S, Sperti C, Pasquali C, Pedrazzoli S, Chierichetti F, Parenti AR. 18FDG PET findings and GLUT-1 expression in IPMNs of the pancreas. J Nucl Med 2008; 49: 2070.
  76. Sperti C, Frison L, Berselli M, Scapinello A, Gasparoni P, Pedrazzoli S. Abdominal localization of Tangier diosease mimicking a pancreatic neoplasm. Eur J Gastroentero,l Hepatol 2008; 20: 1028-31.
  77. Pedrazzoli S, Pasquali C, Guzzinati S, Berselli M, Sperti C. Survival rates and cause of death in 174 patients with chronic pancreatitis. J Gastrointest Surg 2008; 12: 1930-7.
  78. Sperti C, Berselli M, Pasquali C, Pastorelli D, Pedrazzoli S. The aggressive behaviour of solid-pseudopapillary tumor of the pancreas in adults: a case report and review of the literature. World J Gastroenterol 2008; 14: 960-65.
  79. Sperti C, Frison L, Liessi G, Pedrazzoli S. The management of obstructive jaundice in pancreatic cancer. Ann Ital Chir 2007; 78: 469-74.
  80. Sperti C, Bissoli S, Pasquali C, Frison L, Liessi G, Chierichetti F, Pedrazzoli S. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas. Ann Surg 2007; 246: 932-7.
  81. Basso D, Navaglia F, Fogar P, Zambon CF, Greco E, Schiavon S, Fasolo M, Stranges A, Falda A, Padoan A, Fadi E, Pedrazzoli S, Plebani M. DNA repair pathways and mitochondrial DNA mutations in gastrointestinal carcinogenesis. Clin Chim Acta 381: 50-55, 2007.
  82. Navaglia F, Basso D, Fogar P, Sperti C, Greco E, Zambon CF, Stranges A, Falda A, Pizzi S, Parenti A, Pedrazzoli S, Plebani M. Mitochondrial DNA D-loop in pancreatic cancer: somatic mutations are epiphenomena while the germline 16519 T variant worsens metabolism and outcome. Am J Clin Pathol. 2006 Oct;126(4):593-601
  83. Sperti C, Pasquali C, Fiore V, Bissoli S, Chierichetti F, Liessi G, Pedrazzoli S. Clinical usefulness of 18-fluorodeoxyglucose positron emission tomography in the management of patients with nonpancreatic periampullary neoplasms. Am J Surg. 2006 Jun;191(6):743-8.
  84. Blandamura S, Parenti A, Famengo B, Canesso A, Moschino P, Pasquali C, Pizzi S, Guzzardo V, Ninfo V. Three cases of pancreatic serous cystadenoma and endocrine tumour. J Clin Pathol. 2007 Mar;60(3):278-82. Epub 2006 Apr 27.
  85. Basso D, Greco E, Fogar P, Pucci P, Flagiello A, Baldo G, Giunco S, Valerio A, Navaglia F, Zambon CF, Falda A, Pedrazzoli S, Plebani M. Pancreatic cancer-derived S-100A8 N-terminal peptide: a diabetes cause? Clin Chim Acta. 2006 Oct;372(1-2):120-8. Epub 2006 Mar 29.
  86. Pedrazzoli S, Pasquali C, Sperti C, Chierichetti F. 18-fluorodeoxyglucose positron emission tomography and pancreatic cancer. Dig Surg. 2005;22(6):467-8; author reply 468-9. Epub 2006 Mar 16.
  87. Fogar P, Sperti C, Basso D, Sanzari MC, Greco E, Davoli C, Navaglia F, Zambon CF, Pasquali C, Venza E, Pedrazzoli S, Plebani M Decreased total lymphocyte counts in pancreatic cancer: an index of adverse outcome. Pancreas. 2006 Jan;32(1):22-8.
  88. Greco E, Basso D, Fogar P, Mazza S, Navaglia F, Zambon CF, Falda A, Pedrazzoli S, Ancona E, Plebani M. Pancreatic cancer cells invasiveness is mainly affected by interleukin-1beta not by transforming growth factor-beta1. Int J Biol Markers. 2005 Oct-Dec;20(4):235-41.
  89. Tamagno G, Maffei P, Pasquali C, De Carlo E, Martini C, Mioni R, Crivellaro C, Faggian D, Pedrazzoli S, Sicolo N. Clinical and diagnostic aspects of cystic insulinoma. Scand J Gastroenterol. 2005 Dec;40(12):1497-501.
  90. Fogar P, Greco E, Basso D, Navaglia F, Plebani M, Pedrazzoli S. Killer genes in pancreatic cancer therapy. Cell Mol Biol (Noisy-le-grand). 2005 Sep 2;51(1):61-76.
  91. Pizzi S, Azzoni C, Bottarelli L, Campanini N, D’Adda T, Pasquali C, Rossi G, Rindi G, Bordi C. RASSF1A promoter methylation and 3p21.3 loss of heterozygosity are features of foregut, but not midgut and hindgut, malignant endocrine tumours. J Pathol. 2005 Aug;206(4):409-16.
  92. Basso D, Greco E, Fogar P, Pucci P, Flagiello A, Baldo G, Giunco S, Valerio A, Navaglia F, Zambon CF, Pedrazzoli S, Plebani M. Pancreatic cancer-associated diabetes mellitus: an open field for proteomic applications. Clin Chim Acta. 2005 Jul 24;357(2):184-9.
  93. Pasquali C, Sperti C, Lunardi C, Scappin S, Chierichetti F, Liessi G, Pedrazzoli S. Positron emission tomography with fluorodeoxyglucose in gastro-entero-pancreatic tumors: diagnostic role and prognostic implications Suppl Tumori. 2005 May-Jun;4(3):S68-71.
  94. Pasquali C, Sperti C, Baratella P, Liessi G, Pedrazzoli S. Enucleation-resection of pancreatic neuroendocrine tumors: 25 years of experience Suppl Tumori. 2005 May-Jun;4(3):S59-60.
  95. Pedrazzoli S, Pasquali C, Sperti C. Extent of lymphadenectomy in the resection of pancreatic cancer. Analysis of the existing evidence. Rocz Akad Med Bialymst. 2005;50:85-90.
  96. Sperti C, Pasquali C, Decet G, Chierichetti F, Liessi G, Pedrazzoli S. F-18-fluorodeoxyglucose positron emission tomography in differentiating malignant from benign pancreatic cysts: a prospective study. J Gastrointest Surg. 2005 Jan;9(1):22-8; discussion 28-9.
  97. Basso D, Millino C, Greco E, Romualdi C, Fogar P, Valerio A, Bellin M, Zambon CF, Navaglia F, Dussini N, Avogaro A, Pedrazzoli S, Lanfranchi G, Plebani M. Altered glucose metabolism and proteolysis in pancreatic cancer cell conditioned myoblasts: searching for a gene expression pattern with a microarray analysis of 5000 skeletal muscle genes. Gut. 2004 Aug;53(8):1159-66.
  98. Valerio A, Basso D, Fogar P, Falconi M, Greco E, Bassi C, Seraglia R, Abu-Hilal M, Navaglia F, Zambon CF, Gallo N, Falda A, Pedrazzoli S, Plebani M. Maldi-TOF analysis of portal sera of pancreatic cancer patients: identification of diabetogenic and antidiabetogenic peptides. Clin Chim Acta. 2004;343(1-2):119-27.
  99. Sperti C, Pasquali C, Chierichetti F, Ferronato A, Decet G, Pedrazzoli S. 18-Fluorodeoxyglucose positron emission tomography in predicting survival of patients with pancreatic carcinoma. J Gastrointest Surg. 2003 Dec;7(8):953-9; discussion 959-60.
  100. Fogar P, Greco E, Basso D, Habeler W, Navaglia F, Zambon CF, Tormen D, Gallo N, Cecchetto A, Plebani M, Pedrazzoli S. Suicide gene therapy with HSV-TK in pancreatic cancer has no effect in vivo in a mouse model. Eur J Surg Oncol. 2003 Nov;29(9):721-30.
  101. Monti P, Leone BE, Marchesi F, Balzano G, Zerbi A, Scaltrini F, Pasquali C, Calori G, Pessi F, Sperti C, Di Carlo V, Allavena P, Piemonti L. The CC chemokine MCP-1/CCL2 in pancreatic cancer progression: regulation of expression and potential mechanisms of antimalignant activity. Cancer Res. 2003 Nov 1;63(21):7451-61.
  102. Cavallari I, D’Agostino DM, Ferro T, Rosato A, Barzon L, Pasquali C, Fogar P, Theodoropoulou M, Esposito G, Boscaro M, Pagotto U, Tebaldi E, Fallo F, Chieco-Bianchi L, Ciminale V. In situ analysis of human menin in normal and neoplastic pancreatic tissues: evidence for differential expression in exocrine and endocrine cells. J Clin Endocrinol Metab. 2003 Aug;88(8):3893-901.
  103. Sperti C, Pasquali C, Liessi G, Pinciroli L, Decet G, Pedrazzoli S. Pancreatic resection for metastatic tumors to the pancreas. J Surg Oncol. 2003 Jul;83(3):161-6; discussion 166.
  104. Sperti C, Pasquali C, Pastorelli D, Ferronato A, Decet G, Pedrazzoli S. Adenocarcinoma of the pancreas: the rationale for neoadjuvant therapy. Acta Biomed. 2003;74 Suppl 2:91-5.
  105. Pedrazzoli S, Pasquali C, Sperti C. Role of surgery in the treatment of bilio-pancreatic cancer: the European experience. Semin Oncol. 2002 Dec;29(6 Suppl 20):23-30.
  106. Pasquali C, Sperti C, Filipponi C, Pedrazzoli S. Epidemiology of pancreatic cancer in Northeastern Italy: incidence, resectability rate, hospital stay, costs and survival (1990-1992). Dig Liver Dis. 2002;34(10):723-31.
  107. Greco E, Fogar P, Basso D, Stefani AL, Navaglia F, Zambon CF, Mazza S, Gallo N, Piva MG, Scarpa A, Pedrazzoli S, Plebani M. Retrovirus-mediated herpes simplex virus thymidine kinase gene transfer in pancreatic cancer cell lines: an incomplete antitumor effect. Pancreas. 2002 Aug;25(2):e21-9.
  108. Pizzi S, D’Adda T, Azzoni C, Rindi G, Grigolato P, Pasquali C, Corleto VD, Delle Fave G, Bordi C. Malignancy-associated allelic losses on the X-chromosome in foregut but not in midgut endocrine tumours. J Pathol. 2002 Apr;196(4):401-7.
  109. D’adda T, Pizzi S, Azzoni C, Bottarelli L, Crafa P, Pasquali C, Davoli C, Corleto VD, Delle Fave G, Bordi C. Different patterns of 11q allelic losses in digestive endocrine tumors. Hum Pathol. 2002 Mar;33(3):322-9.
  110. Colaut F, Toniolo L, Sperti C, Pozzobon M, Scapinello A, Sartori CA. Autoimmune-like pancreatitis in thymoma with myasthenia gravis. Chir Ital. 2002 Jan-Feb;54(1):91-4.
  111. Basso D, Valerio A, Seraglia R, Mazza S, Piva MG, Greco E, Fogar P, Gallo N, Pedrazzoli S, Tiengo A, Plebani M. Putative pancreatic cancer-associated diabetogenic factor: 2030 MW peptide. Pancreas. 2002 Jan;24(1):8-14.
  112. Sperti C, Pasquali C, Chierichetti F, Liessi G, Ferlin G, Pedrazzoli S. Value of 18-fluorodeoxyglucose positron emission tomography in the management of patients with cystic tumors of the pancreas. Ann Surg. 2001 Nov;234(5):675-80.
  113. Pedrazzoli S, Sperti C, Pasquali C. Pancreatic head resection for noninflammatory benign lesions of the head of the pancreas. 2001 Oct;23(3):309-15.
  114. Canavese G, Azzoni C, Pizzi S, Corleto VD, Pasquali C, Davoli C, Crafa P, Delle Fave G, Bordi C. p27: a potential main inhibitor of cell proliferation in digestive endocrine tumors but not a marker of benign behavior. Hum Pathol. 2001 Oct;32(10):1094-101.
  115. Barzon L, Pasquali C, Grigoletto C, Pedrazzoli S, Boscaro M, Fallo F. Multiple endocrine neoplasia type 1 and adrenal lesions. J Urol. 2001 Jul;166(1):24-7.
  116. Valerio A, Basso D, Mazza S, Baldo G, Tiengo A, Pedrazzoli S, Seraglia R, Plebani M. Serum protein profiles of patients with pancreatic cancer and chronic pancreatitis: searching for a diagnostic protein pattern. Rapid Commun Mass Spectrom. 2001;15(24):2420-5.
  117. Zambon C, Navaglia F, Basso D, Gallo N, Greco E, Piva MG, Fogar P, Pasquali C, Pedrazzoli S, Plebani M. ME-PCR for the identification of mutated K-ras in serum and bile of pancreatic cancer patients: an unsatisfactory technique for clinical applications. Clin Chim Acta. 2000 Dec;302(1-2):35-48.
  118. Piva MG, Navaglia F, Basso D, Fogar P, Roveroni G, Gallo N, Zambon CF, Pedrazzoli S, Plebani M. CEA mRNA identification in peripheral blood is feasible for colorectal, but not for gastric or pancreatic cancer staging. 2000 Nov;59(4):323-8.
  119. Sperti C, Pasquali C, Perasole A, Liessi G, Pedrazzoli S. Macrocystic serous cystadenoma of the pancreas: clinicopathologic features in seven cases. Int J Pancreatol. 2000 Aug;28(1):1-7.
  120. Sperti C, Pasquali C, Ferronato A, Pedrazzoli S. Median pancreatectomy for tumors of the neck and body of the pancreas. J Am Coll Surg. 2000 Jun;190(6):711-6.
  121. Pedrazzoli S, Beger HG, Obertop H, Andren-Sandberg A, Fernandez-Cruz L, Henne-Bruns D, Luttges J, Neoptolemos JP. A surgical and pathological based classification of resective treatment of pancreatic cancer. Summary of an international workshop on surgical procedures in pancreatic cancer. Dig Surg. 1999;16:337-45.
  122. Pedrazzoli S, Pasquali C, Sperti C. General aspects of surgical treatment of pancreatic cancer. Dig Surg. 1999;16(4):265-75.
  123. Sperti C, Pasquali C, Davoli C, Polverosi R, Pedrazzoli S. Mucinous cystadenoma of the pancreas as a cause of acute pancreatitis. Hepatogastroenterology. 1998 Nov-Dec;45(24):2421-4.
  124. Pedrazzoli S, DiCarlo V, Dionigi R, Mosca F, Pederzoli P, Pasquali C, Kloppel G, Dhaene K, Michelassi F. Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group. Ann Surg. 1998 Oct;228(4):508-17.
  125. Fogar P, Basso D, Pasquali C, Piva MG, Brigato L, De Paoli M, Galeotti F, Corsini A, Plebani M. Portal but not peripheral serum levels of interleukin 6 could interfere with glucose metabolism in patients with pancreatic cancer. Clin Chim Acta. 1998 Oct;277(2):181-9.
  126. Pasquali C, Rubello D, Sperti C, Gasparoni P, Liessi G, Chierichetti F, Ferlin G, Pedrazzoli S. Neuroendocrine tumor imaging: can 18F-fluorodeoxyglucose positron emission tomography detect tumors with poor prognosis and aggressive behavior? World J Surg. 1998 Jun;22(6):588-92.
  127. Fogar P, Pasquali C, Basso D, Floreani A, Piva MG, De Paoli M, Melis A, Sperti C, Pedrazzoli S, Plebani M. Transforming growth factor beta, fibrogenesis and hyperglycemia in patients with chronic pancreatitis. J Med. 1998;29(5-6):277-87.
  128. Sperti C, Pasquali C, Pedrazzoli S. Ductal adenocarcinoma of the body and tail of the pancreas. J Am Coll Surg. 1997 Sep;185(3):255-9.
  129. Sperti C, Pasquali C, Pedrazzoli S, Guolo P, Liessi G. Expression of mucin-like carcinoma-associated antigen in the cyst fluid differentiates mucinous from nonmucinous pancreatic cysts. Am J Gastroenterol. 1997 Apr;92(4):672-5.
  130. Militello C, Sperti C, Di Prima F, Pedrazzoli S. Clinical evaluation and safety of loxiglumide (CCK-A receptor antagonist) in nonresectable pancreatic cancer patients. Italian Pancreatic Cancer Study Group. Pancreas. 1997 Apr;14(3):222-8.
  131. Fogar P, Basso D, Pasquali C, De Paoli M, Sperti C, Roveroni G, Pedrazzoli S, Plebani M. Neural cell adhesion molecule (N-CAM) in gastrointestinal neoplasias. Anticancer Res. 1997 Mar-Apr;17(2B):1227-30.
  132. Sperti C, Pasquali C, Piccoli A, Pedrazzoli S. Recurrence after resection for ductal adenocarcinoma of the pancreas. World J Surg. 1997 Feb;21(2):195-200.
  133. Sperti C, Pasquali C, Guolo P, Polverosi R, Liessi G, Pedrazzoli S. Serum tumor markers and cyst fluid analysis are useful for the diagnosis of pancreatic cystic tumors. 1996 Jul 15;78(2):237-43.
  134. Sperti C, Pasquali C, Piccoli A, Pedrazzoli S. Survival after resection for ductal adenocarcinoma of the pancreas. Br J Surg. 1996 May;83(5):625-31.
  135. Rugge M, Sonego F, Sessa F, Leandro G, Capella C, Sperti C, Pasquali C, Di Mario F, Pedrazzoli S, Ninfo V. Nuclear DNA content and pathology in radically treated pancreatic carcinoma. The prognostic significance of DNA ploidy, histology and nuclear grade. 1996 Feb 1;77(3):459-66.
  136. Pedrazzoli S, Sperti C, Pasquali C. An easier technique for end to end pancreaticojejunostomy. HPB Surg. 1996;9(3):141-3.
  137. Borsato N, Chierichetti F, Zanco P, Rubello D, Pasquali C, Pedrazzoli S, Ferlin G. The role of 111In-octreotide scintigraphy in the detection of APUD tumours: our experience in eighteen patients. Q J Nucl Med. 1995 Dec;39(4 Suppl 1):113-5.
  138. Sperti C, Pasquali C, Guolo P, Caldart T, Polverosi R, Caroli A, Colbertaldo F, Pedrazzoli S. Evaluation of cyst fluid analysis in the diagnosis of pancreatic cysts. Ital J Gastroenterol. 1995 Dec;27(9):479-83.
  139. Pedrazzoli S, Sperti C, Pasquali C. Pancreaticoduodenojejunostomy for chronic pancreatitis presenting with an inflammatory mass in the head of the pancreas. 1995 Oct;11(3):289-93.
  140. Sperti C, Pasquali C, Costantino V, Perasole A, Liessi G, Pedrazzoli S. Solitary true cyst of the pancreas in adults. Report of three cases and review of the literature. Int J Pancreatol. 1995 Oct;18(2):161-7.
  141. Fogar P, Pasquali C, Basso D, Sperti C, Panozzo MP, Tessari G, D’Angeli F, Del Favero G, Plebani M. Diabetes mellitus in pancreatic cancer follow-up. Anticancer Res. 1994 Nov-Dec;14(6B):2827-30.
  142. Sperti C, Militello C, Rovati L, Behboo R, Khajeturian E, Perasole A, Alaggio R, Pedrazzoli S. Effect of cholecystokinin analogue caerulein and cholecystokinin antagonist lorglumide on pancreatic carcinogenesis in the rat. J Surg Oncol. 1994 Sep;57(1):11-6.
  143. D’Andrea AA, Costantino V, Sperti C, Pedrazzoli S. Human fibrin sealant in pancreatic surgery: it is useful in preventing fistulas? A prospective randomized study. Ital J Gastroenterol. 1994 Jul-Aug;26(6):283-6.
  144. Pasquali C, Sperti C, D’Andrea AA, Costantino V, Filipponi C, Pedrazzoli S. Clinical value of serum TAG-72 as a tumor marker for pancreatic carcinoma. Comparison with CA 19-9. Int J Pancreatol. 1994;15:171-7.
  145. Pasquali C, Sperti C, D’Andrea AA, Costantino V, Filipponi C, Pedrazzoli S. CA 50 compared with CA 19-9 as a serum tumour marker for pancreatic carcinoma. Ital J Gastroenterol. 1994 May;26(4):169-73.
  146. Sperti C, Pasquali C, Piccoli A, Sernagiotto C, Pedrazzoli S. Radical resection for ampullary carcinoma: long-term results. Br J Surg. 1994 May;81(5):668-71.
  147. Sperti C, Pasquali C, Di Prima F, Rugge M, Petrin P, Costantino V, Canton A, Pedrazzoli S. Percutaneous CT-guided fine needle aspiration cytology in the differential diagnosis of pancreatic lesions. Ital J Gastroenterol. 1994 Apr;26(3):126-31.
  148. Polverosi R, Sbeghen R, Zambelli C, Zanellato E, Sperti C. The role of echography and computed tomography in distinguishing benign cystic neoplasms of the pancreas and biliary tract. A report of 3 cases. Radiol Med (Torino). 1994 Apr;87(4):523-5.
  149. Costantino V, Da Lio C, Sperti C, Petrin P, Pedrazzoli S. Malignant mesenchymal tumors of the breast. Report of 3 new cases Minerva Med. 1994 Mar;85(3):113-6.
  150. Sperti C, Pasquali C, Di Prima F, Baffa R, Pedrazzoli S. Duodenal leiomyosarcoma mimicking a pancreatic pseudocyst. HPB Surg. 1994;8(1):49-52.
  151. Pedrazzoli S, Sperti C, Pasquali C. Prediction of resectability and of surgical risk in pancreatic carcinoma; conditioning factors of survival after resective intervention Chir Ital. 1994;46(2):30-8.
  152. Pasquali C, Sperti C, D’Andrea AA, Costantino V, Filipponi C, Pedrazzoli S. CA50 as a serum marker for pancreatic carcinoma: comparison with CA19-9. Eur J Cancer. 1994;30A(7):1042-3.
  153. Sperti C, Cappellazzo F, Pasquali C, Militello C, Catalini S, Bonadimani B, Pedrazzoli S. Cystic neoplasms of the pancreas: problems in differential diagnosis. Am Surg. 1993 Nov;59(11):740-5.
  154. Sperti C, Bonadimani B, Pasquali C, Piccoli A, Cappellazzo F, Rugge M, Pedrazzoli S. Ductal adenocarcinoma of the pancreas: clinicopathologic features and survival. Tumori. 1993 Oct 31;79(5):325-30.
  155. Sperti C, Pasquali C, Catalini S, Cappellazzo F, Bonadimani B, Behboo R, Pedrazzoli S. CA 19-9 as a prognostic index after resection for pancreatic cancer. J Surg Oncol. 1993 Mar;52(3):137-41.
  156. Costantino V, Pasquali C, Liessi G, Pesce G, Scapinello A, Sperti C, Pedrazzoli S. Adrenal cystic lymphangioma. A case report Minerva Chir. 1992 Dec;47(23-24):1841-4.
  157. Pedrazzoli S, Bonadimani B, Sperti C, Pasquali C, Cappellazzo F, Catalini S, Piccoli A, Militello C. Evaluation of surgical risk in palliation and resection of pancreatic cancer. Perspective study and tables to calculate the risk. Int J Pancreatol. 1992 Dec;12(3):219-26.
  158. Sperti C, Bonadimani B, Militello C, Cappellazzo F, Pedrazzoli S, Guolo P. Testosterone and androgen metabolism in pancreatic cancer. J Clin Gastroenterol. 1992 Sep;15(2):161-2.
  159. Sperti C, Bonadimani B, Guolo P, Militello C, Cappellazzo F, Pasquali C, Pedrazzoli S. Androgen profile in patients with pancreatic carcinoma. Ital J Gastroenterol. 1992 Jul-Aug;24(6):328-31.
  160. Sperti C, Pasquali C, Catalini S, Cappellazzo F, Bonadimani B, Militello C, Pedrazzoli S. Hormonal treatment of unresectable pancreatic cancer with LHRH analogue (goserelin). Eur J Surg Oncol. 1992 Jun;18(3):267-71.
  161. Sperti C, Militello C, Perasole A, Borsato A, Cappellazzo F, Pedrazzoli S. Effect of castration and testosterone replacement on pancreatic carcinogenesis in Syrian hamsters. Tumori. 1992 Apr 30;78(2):75-8.
  162. Liessi G, Pasquali C, D’Andrea AA, Scandellari C, Pedrazzoli S. MRI in insulinomas: preliminary findings. Eur J Radiol. 1992 Jan-Feb;14(1):46-51.
  163. Meggiato T, Basso D, Pasquali C, Angonese C, Bellinvia S, Del Favero G, Fabris C, Di Mario F, Plebani M, Pedrazzoli S, et al. Ca 19-9 in the diagnosis of pancreatic carcinoma. Minerva Med. 1989 May;80(5):431-4.
  164. Bonadimani B, Sperti C, Cappellazzo F, Militello C, Petrin P, Pasquali C, Zannini G, Bonadimani A, Pedrazzoli S. Usefulness of ethyl vinyl acetate bags for total parenteral nutrition in surgery. Minerva Dietol Gastroenterol. 1988 Apr-Jun;34(2):101-4.
  165. Militello C, Sperti C, Marra S, Pasquali C, Bonadimani B, Cappellazzo F, Petrin P, Scandellari C, Pedrazzoli S. Low levels of testosterone in patients with pancreatic carcinoma. Minerva Chir. 1988 Apr 15;43(7):581-6.
  166. Basso D, Fabris C, Meani A, Del Favero G, Vianello D, Angonese C, Meggiato T, Bellinvia S, Fogar P, Petrin P, et al. C reactive protein in pancreatic cancer and chronic pancreatitis. Ann Clin Res. 1988;20:414-6.
  167. Basso D, Fabris C, Panucci A, Del Favero G, Angonese C, Plebani M, Petrin P, Burlina A, Naccarato R. Tissue polypeptide antigen, galactosyltransferase isoenzyme II and pancreatic oncofetal antigen serum determination: role in pancreatic cancer diagnosis. Int J Pancreatol. 1988;3 Suppl 1:S95-100.
  168. Petrin P, De Luca A, Pellicano N, Sperti C, Bonadimani B, Pasquali C, Pedrazzoli S. Clinical and prognostic differences between chronic pancreatitis on a base of alcoholism and that due to biliary lithiasis. Minerva Chir. 1987 Nov 15;42(21):1705-7.
  169. Pedrazzoli S, Pasquali C, Miotto D, Feltrin GP, Petrin P. Transhepatic portal sampling for preoperative localization of insulinomas. Surg Gynecol Obstet. 1987 Aug;165(2):101-6.
  170. Bonadimani B, Sperti C, Stevanin A, Cappellazzo F, Militello C, Petrin P, Pedrazzoli S. Central venous catheter guidewire replacement according to the Seldinger technique: usefulness in the management of patients on total parenteral nutrition. JPEN J Parenter Enteral Nutr. 1987 May-Jun;11(3):267-70.
  171. Pedrazzoli S, Bonadimani B, Sperti C, Cappellazzo F, Piccoli A, Militello C. Forecast of surgical risk in pancreatic cancer. Am J Surg. 1987 Apr;153(4):374-7.
  172. Bonadimani B, Sperti C, Cappellazzo F, Stevanin A, Militello C, Petrin P, Pedrazzoli S. Infections caused by central venous catheters in patients under total parenteral nutrition. Usefulness of Seldinger’s guidewire. Minerva Chir. 1987 Mar 15;42(5):401-6.
  173. Pasquali C, Sperti C, D’Andrea AA, Bonadimani B, Del Favero G, Petrin P, Pedrazzoli S. Evaluation of carbohydrate antigens 19-9 and 12-5 in patients with pancreatic cancer. Pancreas. 1987;2(1):34-7.
  174. Chiappetta A, Sperti C, Bonadimani B, Pasquali C, Militello C, Petrin P, Pedrazzoli S. Surgical experience with adenocarcinoma of the ampulla of Vater. Am Surg. 1986 Nov;52(11):603-6.
  175. Basso D, Fabris C, Del Favero G, Panucci A, Piccoli A, Plebani M, Pedrazzoli S, Baccaglini U, Lise M, Burlina A, et al. The role of CEA, CA 19-9 and TPA in the diagnosis of pancreatic cancer. Evaluation by discriminant analysis Minerva Med. 1986 Apr 14;77(16):613-6.
  176. Panucci A, Del Favero G, Falmis C, Brosolo P, Basso D, Pedrazzoli S, Baccaglini U, Marchioro L, Bonvilini P, Naccarato R. Biohumeral markers in the diagnosis of pancreatic carcinoma. Recenti Prog Med. 1985 Jul-Aug;76(7-8):385-91.
  177. Sperti C, Bonadimani B, Militello C, Costantino V, Fiore D, Petrin P, Pedrazzoli S. Intestinal duplication in the adult. Minerva Chir. 1984 May 31;39(10):843-6.
  178. Pedrazzoli S, Sperti C, Militello C, Chiappetta A, Pomerri F, Petrin P. Duodenal leiomyosarcoma and its multiple recurrences: good surgical result after three years of follow-up. Ital J Surg Sci. 1984;14(4):321-6.
  179. Pedrazzoli S, Petrin P, Pasquali C, Militello C, Sperti C, Fregonese V, Simini G. Ranitidine reverses cimetidine-induced mental confusion in a patient with Zollinger-Ellison syndrome. Arch Surg. 1983 Feb;118(2):256. No abstract available.
  180. Sperti C, Militello C, Chiappetta A, Bonadimani B, Biondetti P, Petrin P, Pedrazzoli S. Cystic neoplasms of the pancreas. Ital J Surg Sci. 1983;13(3):217-22.
  181. Pedrazzoli S, Feltrin G, Dodi G, Miotto D, Pasquali C, Cevese PG. Usefulness of transhepatic portal catheterization in the treatment of insulinomas. Br J Surg. 1980 Aug;67(8):557-61.

Capitoli di libro pubblicati.

  1. Pedrazzoli S, Sperti C. Resection for neoplasms of the pancreas. Central resection. Atlas of Upper Gastrointestinal and Hepato-Pancreato-Biliary Surgery, Chapter 90. Clavien PA, Sarr MG, Fong Y, Miyazaki M Editors. Second Edition. Springer-Verlag Berlin Heidelberg 2016. Pg. 847-57.
  2. Sperti C. Follow-up. In Pedrazzoli S, Silvestrini R: “Basi scientifiche per la definizione di line guida in ambito clinico per I Tumori del Pancreas”. Alleanza contro il cancro, Milano, Marzo 2010.
  3. Pedrazzoli S, Pasquali C, Sperti C, Avogaro F. Management of cancer pain. In Beger HG et al. “The pancreas: an integrated textbook of basic science, medicine, and surgery”. 2nd edition, Blackwell pub.ed., 2008, pp. 757-764.
  4. Pedrazzoli S, Pasquali C, Sperti C. Central resection. In: Clavien PA, Sarr MG, Fong Y. “Atlas of Upper Gastrointestinal and Hepato-Pancreato-Biliary Surgery”. Springer Ed., Berlin Heidelberg New York, 2007, pp 781-790
  5. Pasquali C., Decet G. (2006). Emostasi e coagulazione. In: Lise M. Chirurgia per le professioni sanitarie. (voI. I, pp. 27-34). PADOVA: Piccin (ITALY).
  6. Pasquali C., Lunardi C. (2006). Intestino Tenue. In: Lise M. Chirurgia per le professioni sanitarie. (voI. Il, pp. 537-548). PADOVA: Piccin (ITALY).
  7. Pedrazzoli S., Pasquali C., Sperti C. (2006). Chirurgia del pancreas endocrino. In: Pedrazzoli S. Nuovo Trattato di Tecnica Chirurgica Pancreas – Peritoneo – Retroperitoneo – Surrene – Milza. (voI. 6, pp. 281-286). TORINO: UTET (ITALY).
  8. Pedrazzoli S., Pasquali C., Sperti C. (2006). Chirurgia della pancreatite cronica: Interventi derivativi. In: Pedrazzoli S. Nuovo Trattato di Tecnica Chirurgica Pancreas – Peritoneo – Retroperitoneo – Surrene – Milza. (voI. 6, pp. 189-201). TORINO: UTET (ITALY).
  9. Pedrazzoli S., Pasquali C., Sperti C. (2006). Le exeresi del duodeno con conservazione della testa del pancreas. In: Pedrazzoli S. Nuovo Trattato di Tecnica Chirurgica: Pancreas – Peritoneo. Retroperitoneo – Surrene – Milza. (voI. 6, pp. 88-90). TORINO: UTET (ITALY).
  10. Pedrazzoli S., Pasquali C., Sperti C. (2006). Duodenocefalopancreasectomia (DCP). In: Pedrazzoli S. Nuovo Trattato di Tecnica Chirurgica: Pancreas – Peritoneo – Retroperitoneo – Surrene – Milza. (voI. 6, pp. 92-110). TORINO: UTET (ITALY).
  11. Pedrazzoli S., Pasquali C., Sperti C. (2006). Anatomia. In: Pedrazzolì S. Nuovo Trattato di Tecnica Chirurgica: Pancreas – Peritoneo – Retroperitoneo – Surrene – Milza. (voI. 6, pp. 1-31). TORINO: UTET (ITALY).
  12. Pedrazzoli S., Pasquali C., Sperti C. (2006). Le exeresi cefalopancreatiche con conservazione del duodeno (DPPHR). In: Pedrazzoli S. Nuovo Trattato di Tecnica Chirurgica: Pancreas – Peritoneo Retroperitoneo – Surrene – Milza. (voI. 6, pp. 77-87). TORINO: UTET (ITALY).
  13. Pedrazzoli S., Pasquali C., Sperti C. (2002). Le neoplasie endocrine dell’apparato digerente. In: Crepaldi G., Baritussio A Trattato di Medicina Interna. (pp. 1059-1082). PADOVA: PICCIN (ITALY).
  14. Pasquali C., Sperti C., Pedrazzoli S. (2001). Tecniche scintigrafiche. In: Rabitti P.G., Visconti M., Galloro G., Uomo G., E CONSIGLIO DIRETTIVO AISP. Neoplasie pancreatiche esocrine ed endocrine. (pp. 67-76). NAPOLI: Forma Communications Editore (ITALY).
  15. Pedrazzoli S., Pasquali C., Sperti C. (2001). Palliazione chirurgica. In: Rabitti P.G., Visconti M., Galloro G. Uomo G., E CONSIGLIO DIRETTIVO AISP. Neoplasie pancreatiche esocrine ed endocrine. (pp. 91-100). NAPOLI: Forma Communications Editore (ITALY).
  16. Pedrazzoli S., Sperti C., Pasquali C., Ferronato A., Decet G., Petrin P., Chierichetti F., Liessi G. (2001). Ruolo della PET nella scelta della terapia dei tumori cistici del pancreas. In: Melita P., Cucinotta E., Palmieri R., Melita G. La chirurgia geriatrica nel terzo millennio. (pp. 299-304). NAPOLI: Giuseppe De Nicola (ITALY).
  17. Pasquali C., Sperti C., Pedrazzoli S. (2000). Tumor markers in the diagnosis and prognosis of pancreatic tumors. In: Dervenis C.G.,Bassi C. Pancreatic tumors. Achievements-and Prospective. (pp. 111-116). STUTTGART: Georg Thieme Verlag (GERMANY).
  18. Pedrazzoli S., Pasquali C., Sperti C. (2000). Definition in Pancreatic cancer Surgery – Castelfranco Consensus Meeting. In: Dervenis C.G.,Bassi C. Pancreatic tumors. Achievements and Prospective. (pp. 138-146). STUTTGART: Georg Thieme Verlag (GERMANY).
  19. Pedrazzoli S., Pasquali C., Sperti C. (2000). Lymphadenectomy in treatment of periampullary and pancreatic cancer: yes or no. In: Bassi C. Up-date in pancreatic Surgery. (pp. 91-108). LONDON: Foxwell and Davies Ltd (UNITED KINGDOM).
  20. Pedrazzoli S., Pasquali C., Sperti C. Il problema “Carcinoma pancreatico” in 3 UU.LL.SS. del Veneto, 1990-1992. Monografia, pp. 1-32, 1998.
  21. Pasquali C. (1996). Hypergastrinemia. In: Herrera M.F., Garber I.L., Rodrigo J.R., Fernandez M.C. Endocrinologia. Controversias Medico-Quirurgicas. (pp. 203-206). MEXICO CITY: Mc Grew-Hill Interamericana (MEXICO).
  22. Pedrazzoli S., Pasquali C., Sperti C. (1996). La pancreatite acuta. In: Ferrarese S. Manuale di Chirurgia. (pp. 361-368). ROMA: CIC Edizioni Internazionali (ITALY).
  23. Pedrazzoli S., Pasquali C., Sperti C. (1996). Ipergastrinismi secondari e primitivi. In: Federspil G., Sicolo N. Progressi clinici in endocrinologia. (voI. IX (4), pp. 13-38). Collana: Progressi Clinici: Medicina. PADOVA: Piccin (ITALY).
  24. Pedrazzoli S., Pasquali C., Sperti C. (1995). Tumor-Associated Antigen: Clinical practice and future. In: Pederzoli P., Cavallini G., Bassi C. Facing the pancreatic dilemma. Update of medicai and surgical pancreatology. (pp. 273-282). BERLlN: Springer Verlag (GERMANY).
  25. Pedrazzoli S., Pasquali C., Alfano D’Andrea A., Filipponi C. (1993). Revisione dell’uso della somatostatina long-acting nei tumori endocrini gastro-entero-pancreatici. In: Biliotti G.C. Indicazioni della somatostatina long-acting (octreotide)in patologia digestiva. (pp. 101-110). ROMA: Mediprint s.r.l. (ITALY).
  26. Costantino V., Petrin P., Pasquali C., Liessi G., Pedrazzoli S. (1992). Use of fibrin sealant in the treatment of pancreatic fistulas. In: Pederzoli P. Pancreatic Fistulas. (pp. 201-210). NEW-YORK: Springer-Verlag (UNITED STATES).
  27. Rubello D., Girelli M.E., Luisetto G., Opportuno A., Pasquali C., Piccolo M., Busnardo B. (1990). Esiste un tono serotoninergico modulante la secrezione della calcitonina nell’uomo? In: De Bastiani G. Osteoporoses and their treatment. (pp. 23-26). BOLOGNA: Monduzzi Editore.
  28. Pedrazzoli S., Sperti C., Cappellazzo F. Ghiandole surrenali. In Lise M, “Chirurgia per infermieri”, 111 ediz, Piccin Ed, Padova 1990, pp. 621-32.
  29. Militello C., Pasquali C., Pedrazzoli S. (1989). Stomaco e duodeno. In: Lise M. Chirurgia per Infermieri. (pp. 451-474). PADOVA: Piccin (ITALY).
  30. Pedrazzoli S., Pasquali C., Canale M., Militello C., Alfano A., Catalini S., Feltrin G. (1989). Chirurgia dei tumori endocrini del pancreas. In: Dobrilla G., Andriulli A. Attualità in tema di pancreas esocrino ed endocrino. (pp. 247-256). VERONA: Cortina international (ITALY).
  31. Pedrazzoli S., Pasquali C., Fregonese V., Militello C., Petrin P. (1983). Impiego della Ranitidina nel trattamento della Sindrome di Zollinger-Ellison. In: Barbara L., Dobrilla G. Ranitidina: il nuovo H2 antagonista. (pp. 199-207). VERONA: Edizioni Libreria Cortina (ITALY).
  32. Pedrazzoli S., Pasquali C., Cavinato A (1981). I tumori endocrini del pancreas. In: Lise M., Nitti D., Rossi CR. Attualità in tema di tumori dell’apparato digerente. (pp. 71-88). PADOVA: Piccin (ITALY).
  33. Pedrazzoli S., Sperti C., Militello C. Il carcinoma del pancreas esocrino. In Lise M., Nitti D., Rossi C.R. “Attualità in tema di tumori dell’apparato digerente”, Piccin Ed, Padova 1981, pp. 89-102.